NTX-301 in MDS/AML

Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia Intervention:   Drug: NTX-301 Sponsor:   University of Alabama at Birmingham Not yet recruiting

Source: ClinicalTrials.gov - November 19, 2019 Category: Research Source Type: clinical trials